elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Ryanodine receptor
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Ryanodine receptor
RIS
0.001
(Research Intensity Score)
Papers
121
Top papers
Mitochondrial calcium exchange in physiology and disease
2021 · 410 citations
Regulation of calcium homeostasis in endoplasmic reticulum–mitochondria crosstalk: implications for skeletal muscle atrophy
2025 · 68 citations
Microglial P2Y6 calcium signaling promotes phagocytosis and shapes neuroimmune responses in epileptogenesis
2024 · 87 citations
Calcium’s Role and Signaling in Aging Muscle, Cellular Senescence, and Mineral Interactions
2023 · 71 citations
Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
2023 · 78 citations
Newest papers
Advanced modelling of RYR1-related myopathies using human iPS cells and 3D engineered skeletal muscles
2026
Molecular genetics of skeletal muscle diseases associated with abnormal excitation–contraction coupling
2026
Gain-of-function mutation of type 2 ryanodine receptor attenuates dopaminergic neuron development associated with Ca2+ overload-triggered oxidative damage in mitochondria
2026
β1- and β2-adrenergic receptor mediated spontaneous contractions and ryanodine receptor channel opening in human failing heart
2026
Heterosynaptic NMDA receptor plasticity in hippocampal dentate granule cells
2026
A sample from the 100 top papers behind Ryanodine receptor.
Create a free account to browse them all →
Ryanodine receptor's history
Research intensity over time
Explore Ryanodine receptor's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Ryanodine receptor's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link